glp-1 brain inflammation for Weight Loss and Diabetes The metabolic actions of GLP‐1
Description
Gut 2025;74:284-94.ArticlePubMed 102
10 GLP-1 receptor agonists (GLP-1RAs), or incretin mimetics, are currently among the most promising drugs for adjusting metabolic function, playing significant roles in the management of T2DM, and some have been approved for obesity management
Yang CS, Wang H, Sheridan ZP
Neuron 39(6):889909
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Early intervention is key to preventing long-term complications
